Cephalex

Quick links to important sections

Cephalex

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cephalex

Quick Facts

Property Description
Active ingredient Cephalexin monohydrate
Form Capsules, tablets, and powder for oral suspension
Pharmacological class First-generation cephalosporin, β-lactam antibiotic
Common purpose Addresses bacterial infections by eliminating susceptible bacteria
Origin Semisynthetic compound

What Type of Antibiotic is Cephalex (Cephalexin)?

Cephalex is a recognized brand name for the medicine whose active ingredient is Cephalexin monohydrate, a compound classified as a semisynthetic β-lactam antibiotic. Its general therapeutic purpose is to address infections by acting as a powerful bactericidal agent, directly targeting and eliminating susceptible bacteria in the body. The drug is classified as a first-generation cephalosporin, which is a well-established oral subgroup supported by extensive pharmacological studies for its effectiveness against sensitive organisms.

Cephalexin is a type of antibiotic specifically classified as a first-generation cephalosporin. This classification means it is chemically related to penicillins but has a distinct structure that allows it to effectively kill bacteria through bactericidal action, rather than just inhibiting their growth. The medicine is a semisynthetic compound, meaning its structure is chemically derived and modified from a naturally occurring fungal substance, allowing for stable oral administration, which is a key distinguishing feature of this cephalexin molecule compared to other antibiotics in its class.


Composition and Available Forms of Cephalexin

The medicine is a single active ingredient product containing Cephalexin monohydrate, which is the component responsible for the antibacterial effect. Cephalexin is prepared for oral administration and is available in multiple dosage forms, including solid forms such as capsules and tablets. It is also commonly supplied as a powder for oral suspension, which is mixed with an aqueous vehicle system to create a liquid. This liquid form is often specifically formulated and clinically recognized for its reliable palatability when administered to pediatric patients. All forms deliver the same core active ingredient, differing only in the excipients used to ensure stable and effective delivery of the drug, which is typical for prescription-only (Rx) antibacterial agents.

What side effects are possible with Cephalex?

Possible Side Effects and Safety Information

The official safety profile for Cephalexin (Cephalex) details documented adverse reactions and specific safety constraints, categorized in line with government regulatory standards (e.g., FDA, EMA). Side effects are classified by frequency and grouped according to the body system affected.

Adverse Reaction Scope

Classification Aspect Description (Based on Regulatory Labels)
Common Side Effects Include gastrointestinal disturbances such as diarrhea and nausea (affecting 1 to 10 users in 100).
Uncommon Side Effects Affecting 1 to 10 users in 1,000, these include skin reactions like rash and urticaria, as well as eosinophilia and transient increases in liver enzymes.
System-Organ Classes Adverse reactions are grouped by physiological impact, including Gastrointestinal Disorders, Skin and Subcutaneous Tissue Disorders, Immune System Disorders, and Renal and Urinary Disorders.

Serious Safety Considerations

The regulatory label documents the potential for rare but serious adverse reactions. These include severe allergic events such as Anaphylaxis and Angioedema. Severe intestinal inflammation, known as Pseudomembranous Colitis, which is associated with Clostridium difficile, is also a documented risk. Additionally, cephalexin is contraindicated for any individual with a history of serious hypersensitivity or allergy to cephalosporins or other beta-lactam antibiotics.

Population and Duration-Related Safety

Caution is specified for certain patient populations. Individuals with impaired renal function and older adults may require specific monitoring or adjustment, as the medicine is primarily eliminated by the kidneys. Furthermore, prolonged use carries a documented risk of superinfection due to the overgrowth of non-susceptible organisms. The development of diarrhea, including severe colitis, can occur during or even after the discontinuation of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Cephalexin (Cephalex) establishes specific clinical signs and mandated emergency procedures for managing an overdose.

Documented Clinical Manifestations

Following acute oral ingestion, documented manifestations may include severe gastrointestinal distress, presenting as nausea, vomiting, epigastric pain, and diarrhea. Reports in pediatric cases have also specifically detailed the presence of haematuria (blood in the urine).

Risk of Severe Outcomes

The most severe outcome described in regulatory prescribing information is the potential for seizures. This risk is particularly noted in patients with underlying impaired renal function, which can lead to excessively high systemic drug concentrations.

Mandated Emergency Action

If an overdose is suspected, immediate medical attention is required. You must contact a Poison Control center or call local emergency services immediately if the individual has collapsed, is experiencing a seizure, or has trouble breathing.

Official Supportive Management

Treatment for overdosage is primarily supportive in nature, as no specific antidote is known. For severe cases, regulatory documents mandate close clinical and laboratory monitoring of the patient's renal, hepatic, and haematological functions. Gastrointestinal decontamination is generally considered unnecessary unless the dose significantly exceeds the normal therapeutic daily amount.

Therapeutic Uses of Cephalex

Cephalexin is a medication commonly used across conditions presenting with acute episodes of bacterial infections affecting the skin, respiratory tract, ears, and urinary system. The therapeutic uses of Cephalexin are well-established and are applied across domains where additional symptomatic support is needed to ease the overall symptom burden.


Symptom Support and Common Uses

Cephalex is commonly used to manage bacterial infections, including skin and soft tissue infections (like cellulitis and abscesses), certain upper respiratory conditions (such as strep throat and tonsillitis), middle ear infections (otitis media), and genitourinary tract infections (like bladder infections).

The medication is used to help address symptom clusters that may become intense or disruptive. “It is applied in clinical settings that involve acute or unstable symptom patterns,” where the goal is to contribute to improved comfort and stability. For instance, in urinary tract conditions, it is relevant when supportive symptom management is appropriate to ease manifestations like painful or frequent urination, assisting with maintaining functional stability. In skin and ear infections, it supports the patient during difficult episodes by easing distress caused by localized swelling or pain.


Quick Fact: Relief for Inflammatory Symptoms (The medication supports the body’s process in addressing the bacterial cause, which may contribute to easing redness, swelling, and localized discomfort.)

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Cephalexin — Official Regulatory Information

Populations for whom use is contraindicated: The medicine must not be used in patients with a known hypersensitivity or allergy to cephalexin or any other cephalosporin class antibacterial drug. Due to the potential for cross-sensitivity, the drug is also contraindicated for individuals with a history of a serious reaction, such as anaphylaxis, to penicillins.


Age-related eligibility rules: Age Group Eligibility Status (Regulatory)
Adults and Adolescents Eligible for standard use.
Pediatric Patients (ge 1 year) Use is generally established.
Infants (< 1 year) Use is often classified as not established for all indications.
Older Adults (Geriatric) Eligible, but renal function assessment is often required due to age-related decline.

Condition-specific eligibility rules: Condition Eligibility Classification (Regulatory)
Impaired Renal Function Use is restricted; a mandatory adjustment to the regimen is required to prevent drug accumulation.
Gastrointestinal History Use is conditional; caution is advised, particularly for patients with a history of colitis.
Pregnancy and Lactation Use is permitted when clearly needed but officially classified as requiring caution.

Official regulatory documents define Cephalexin eligibility through absolute contraindications based on drug class allergy and through restrictions based on patient physiological status, such as renal impairment. Use is deemed conditional in specific populations, including pregnant or breastfeeding women and those with a history of colitis, thereby establishing the official patient boundaries for the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Cephalexin is structured around pharmacokinetic interference with renal clearance and pharmacodynamic risks associated with certain co-administered drug classes. This information is based strictly on government prescribing documents.

Drug-Drug Interactions (Official Regulatory Statements)

Interacting Substance Official Interaction Pattern
Probenecid Inhibits the renal excretion of Cephalexin, resulting in increased Cephalexin plasma concentrations and systemic exposure.
Metformin Cephalexin decreases Metformin's mean renal clearance, which leads to increased Metformin plasma exposure (Cmax and AUC).
Anticoagulant Therapy Cephalosporins are associated with a potential for a prolonged prothrombin time; monitoring is necessary.
Nephrotoxic Agents (e.g., Aminoglycosides, Furosemide) Co-administration may increase the documented risk of nephrotoxicity.

Non-Medicinal Substance Interactions and Rules

Zinc Supplements: Oral products containing zinc may interfere with the gastrointestinal absorption of Cephalexin. To avoid reduced absorption, these supplements should be administered at least three hours after the Cephalexin dose.

Food Intake: Cephalexin may be given without regard to meals. Although food may delay absorption, the total amount of the drug absorbed is not appreciably altered according to regulatory documentation.

Alcohol: The official prescribing information for Cephalexin does not document a direct chemical or pharmacokinetic interaction with alcohol.

Mechanism of Action

How Cephalex Works

The mechanism of Cephalexin results in the elimination of susceptible bacteria by compromising their structural integrity. It functions as a bactericidal agent, meaning it actively kills the microbe rather than just inhibiting its growth.


Molecular Targeting of Penicillin-Binding Proteins (PBPs)

Cephalexin exerts its initial action through the irreversible inhibition of key bacterial enzymes known as Penicillin-Binding Proteins ( PBPs) (specifically transpeptidases). The drug's structure mimics the natural building blocks of the bacterial cell wall, covalently binding to and inactivating the PBPs. This molecular interaction engages mechanisms that halt the synthesis of the bacterial cell wall.


Initiating the Cell Lysis Cascade

The inhibition of PBPs halts the final cross-linking step of the peptidoglycan polymer, which is necessary for a rigid cell wall. This leads to the buildup of non-rigid cell material and immediate failure to withstand the high internal osmotic pressure of the cell. This cascade results in the rapid rupture and destruction ( lysis) of the microbe, leading to the mass destruction and clearance of the microbe from the biological system.


️ Mechanism Limitations and Bacterial Defense

The mechanism is constrained when bacteria engage in counter-defense, primarily through the production of beta-lactamase enzymes. These enzymes chemically inactivate the drug by breaking its beta-lactam ring before it can reach the PBPs, neutralizing the intended bactericidal effect. This domain highlights the biological context where targeted pathway interference becomes ineffective due to enzymatic modification.

Dosage and Administration Information

How Cephalex is Administered

Cephalexin is a medication solely approved for oral administration and is supplied as capsules, tablets, or powder for oral suspension. The administration is flexible concerning mealtimes, as the drug may be taken with or without food. For the liquid suspension form, the powder must be reconstituted with water at the time of dispensing, and the resulting liquid must be shaken well before each dose is precisely measured.


Official Dosing and Frequency Requirements

The standard adult regimen is administered in equally divided doses, typically 250 mg every 6 hours (four times daily) or 500 mg every 12 hours (twice daily). The maximum labeled daily dose for more severe infections is defined as 4 grams in divided doses. Pediatric dosing is weight-based, ranging from 25 to 100 mg/kg/day depending on the specific condition being addressed.


Course Duration and Population Adjustments

The duration of therapy generally lasts 7 to 14 days. However, when addressing infections caused by beta-hemolytic streptococci, treatment must be completed for a minimum of 10 days. The full prescribed course must always be completed. The official instructions also mandate specific dose adjustments for adult patients with reduced kidney function, specifically for those with Creatinine Clearance <30 mL/min, requiring a reduction in dose or extension of the dosing interval.

Recent Clinical Evidence

Recent Clinical Evidence

Overview of Clinical Research

Cephalex (Cephalexin) is a first-generation cephalosporin antibiotic. Research and clinical trials have focused on its use for the treatment of various bacterial infections, including those affecting the respiratory tract, skin and soft tissue, bone, and genitourinary system.

Studies investigated the compound's effect against susceptible Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae, and certain Gram-negative organisms, including E. coli.


Key Study Findings

Pharmacokinetics and Administration

Studies investigated dosages to establish systemic exposure and metabolism. Data indicates the compound is rapidly and well-absorbed from the gastrointestinal tract following oral administration. It is primarily excreted unchanged through the urine.

Research has examined the implications of co-administration with other substances. For example, some studies noted that probenecid may decrease the excretion rate of the compound, potentially leading to increased concentrations.

Adverse Events and Tolerability

Researchers collected data on adverse events in study participants across various clinical trials. The most frequently reported adverse events include diarrhea, nausea, and vomiting.

  • Hypersensitivity: Rare, but serious, hypersensitivity reactions, including severe skin conditions and anaphylaxis, have been reported across the cephalosporin class of drugs. Researchers collected information on the potential for cross-sensitivity with penicillin-allergic patients.
  • Long-Term Monitoring: Research indicates that prolonged use of antibacterial agents may alter the normal flora of the colon, with Clostridium difficile-associated diarrhea being a potential adverse event monitored by researchers.

Key Studies & References

  1. Cephalosporins and the risk of Clostridium difficile infection: a systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Cephalex (FAQ)

Q: What is Cephalex (cephalexin) used for?

Cephalex (cephalexin) is an antibiotic used to treat a variety of bacterial infections. It belongs to a class of drugs called cephalosporin antibiotics.

It is commonly prescribed for:

  • Respiratory tract infections (like tonsillitis, pharyngitis)
  • Ear infections (otitis media)
  • Skin and soft tissue infections
  • Bone infections (osteomyelitis)
  • Genitourinary tract infections

It works by stopping the growth of bacteria, but it is not effective against viruses (such as the common cold or flu).

Q: How should I take Cephalex?

Cephalex should be taken exactly as prescribed by your healthcare provider. It is usually taken by mouth with or without food, but taking it with food may help decrease stomach upset.

  • Take the medicine at evenly spaced intervals.
  • It is crucial to complete the full course of treatment, even if you start feeling better. Stopping the medication too soon may allow bacteria to continue growing, which could lead to a relapse of the infection or antibiotic resistance.
  • For liquid suspensions, shake the bottle well before each dose and use a special measuring spoon or cup, not a household spoon, to measure the dose.

Q: What are the common side effects of Cephalex?

Like all medications, Cephalex can cause side effects. The most common side effects are generally mild and temporary and may include:

  • Diarrhea
  • Nausea and vomiting
  • Stomach pain
  • Indigestion

If you experience severe watery or bloody diarrhea, especially if it is persistent, contact your doctor immediately as it could be a sign of a more serious condition.

Q: What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed one. If you are unsure, contact your healthcare provider or pharmacist for guidance.

Q: Can I take Cephalex if I am allergic to penicillin?

Tell your healthcare provider if you have ever had an allergic reaction to penicillin or other antibiotics. While Cephalex is in a different class of antibiotics (cephalosporins), there is a possibility of a cross-sensitivity or cross-reactivity reaction, which means you may also be allergic to Cephalex.

Your doctor will assess your history and decide if Cephalex is safe for you to take or if an alternative antibiotic is necessary.

How should Cephalex be stored and disposed of?

Storage and Disposal Conditions for Cephalexin

Cephalexin storage requirements differ by form. Capsules and tablets must be stored in the original, tightly closed container at controlled room temperature (20 C to 25 C) and protected from excessive moisture and heat.

The reconstituted oral suspension requires storage in a refrigerator (2 C to 8 C) and must not be frozen. The liquid suspension is stable for 14 days under refrigeration, after which the unused portion must be discarded.

All forms must be kept out of the sight and reach of children.

Expired or unused medicine should be disposed of via a drug take-back program or by following the official household disposal method of mixing the product with an undesirable substance before placing it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cephalex found in:

A-Z Index: